These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

250 related items for PubMed ID: 5509491

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Neutralization of extrapyramidal side-effects with Methixene.
    Maller O, Heller S.
    Dis Nerv Syst; 1971 Jun; 32(6):409-15. PubMed ID: 5570695
    [No Abstract] [Full Text] [Related]

  • 3. A survey of extrapyramidal manifestations in the inpatient population of a psychiatric hospital.
    Lehmann HE, Ban TA, Saxena BM.
    Laval Med; 1970 Sep; 41(7):909-16. PubMed ID: 5509489
    [No Abstract] [Full Text] [Related]

  • 4. A survey of extrapyramidal manifestations in patients attending an after care clinic of a psychiatric hospital.
    Guttman H, Lehmann HE, Ban TA.
    Laval Med; 1970 Apr; 41(4):449-55. PubMed ID: 5515661
    [No Abstract] [Full Text] [Related]

  • 5. [Long-acting antiparkinson agents. I. Pilot study on benzetimide (342 cases)].
    Korn M, Pinchard A, Breulet M, Goffioul F, Bobon J.
    Acta Psychiatr Belg; 1971 Mar; 71(2):65-75. PubMed ID: 5560276
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa, Fleĭs EP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Mar; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Antiparkinson medication in the treatment of extrapyramidal side effects: single of multiple daily doses?
    Neu C, Dimascio A, Demirgian E.
    Curr Ther Res Clin Exp; 1972 May; 14(5):246-51. PubMed ID: 4623975
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Complex persisting dyskinesia, secondary to neuroleptic therapy].
    Castaigne P, Lapresle J, Chain F.
    Rev Neurol (Paris); 1969 Mar; 120(3):215-9. PubMed ID: 5343991
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical study of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Nardini M, Fanali A, Sorgonà F, Vergnano M, Fieschi G.
    Minerva Med; 1971 Oct 31; 62(82):4020-3. PubMed ID: 5125070
    [No Abstract] [Full Text] [Related]

  • 17. [On the mode of action and the question of central organic late damages of continuous neuroleptic treatment].
    Haddenbrock S.
    Nervenarzt; 1966 May 31; 37(5):199-203. PubMed ID: 5298253
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Action of amantadine in extrapyramidal syndromes caused by neuroleptics].
    Fanali A, Nardini M, Sorgona F.
    Sist Nerv; 1970 May 31; 22(5):273-85. PubMed ID: 5514245
    [No Abstract] [Full Text] [Related]

  • 20. [Late irreversible extrapyramidal syndrome following neuroleptic use].
    Boucebci M.
    Acta Psychiatr Belg; 1972 Mar 31; 72(2):233-40. PubMed ID: 5056017
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.